Olympus® GI endoscopy systems are used by physicians to help them to diagnose, treat, and observe diseases and disorders of the upper and lower GI tract such as acid reflux, ulcers, Crohn's disease, Celiac disease, and colorectal cancer (CRC). An endoscope is commonly used during a screening colonoscopy, when a gastroenterologist examines the lining of the colon and may remove any potentially cancerous growths, known as polyps. The addition of new imaging technologies in the EVIS X1 endoscopy system may help physicians to visualize these abnormalities.
CRC represents the third most common cancer diagnosis for men and women with an estimated 153,000 cases diagnosed annually, according to the American Cancer Society. CRC is a preventable and treatable disease, however, with a 5-year survival rate of up to 91%, if caught at a localized stage.
For more information, visit the EVIS X1 endoscopy system page. For a demonstration, visit the Olympus booth #911 at ACG. Live demonstrations of the new imaging technologies will be offered during ACG 5 p.m. Oct. 22 and 11 a.m. Oct. 23-24. Visit the Olympus website for information on the entire gastroenterology portfolio.
As a leading medical technology company, Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Olympus' portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of endotherapy instruments. For more information, visit medical.olympusamerica.com.
Back to HCB News
